Floating Button
Home News Funds

CK Hutchison-backed VC Longliv supports artificial intelligence-dependent blood testing with latest investment

Amala Balakrishner
Amala Balakrishner • 2 min read
CK Hutchison-backed VC Longliv supports artificial intelligence-dependent blood testing with latest investment
Together with other investors such as Koch Disruptive Technologies based in the US and Israel-headquartered OurCrowd, Longliv is investing US$71 million ($97.5 million) in the company.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

CK Hutchison-backed venture capital fund Longliv ventures has just put forth a follow-on investment in Israel-based start-up Sight Diagnostics.

CK Hutchison is the parent company of the Singapore-listed, Hong Kong-based Hutchison Port Holdings.

Together with other investors such as Koch Disruptive Technologies based in the US and Israel-headquartered OurCrowd, Longliv is investing US$71 million ($97.5 million) in the company.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.